Solesence (NASDAQ:SLSN – Get Free Report) and Rejuvel Bio-Sciences (OTCMKTS:NUUU – Get Free Report) are both consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations and dividends.
Analyst Recommendations
This is a summary of current ratings for Solesence and Rejuvel Bio-Sciences, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Solesence | 1 | 0 | 0 | 0 | 1.00 |
| Rejuvel Bio-Sciences | 0 | 0 | 0 | 0 | 0.00 |
Given Rejuvel Bio-Sciences’ higher possible upside, analysts plainly believe Rejuvel Bio-Sciences is more favorable than Solesence.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Solesence | 1.72% | 6.53% | 1.94% |
| Rejuvel Bio-Sciences | N/A | N/A | N/A |
Institutional & Insider Ownership
70.2% of Solesence shares are held by institutional investors. 4.8% of Solesence shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Risk & Volatility
Solesence has a beta of 1.09, suggesting that its stock price is 9% more volatile than the S&P 500. Comparatively, Rejuvel Bio-Sciences has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500.
Earnings and Valuation
This table compares Solesence and Rejuvel Bio-Sciences”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Solesence | $62.15 million | 1.32 | $4.24 million | $0.01 | 116.00 |
| Rejuvel Bio-Sciences | N/A | N/A | N/A | N/A | N/A |
Solesence has higher revenue and earnings than Rejuvel Bio-Sciences.
Summary
Solesence beats Rejuvel Bio-Sciences on 8 of the 9 factors compared between the two stocks.
About Solesence
Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications. The company was incorporated in 1989 and is headquartered in Romeoville, Illinois.
About Rejuvel Bio-Sciences
Rejuvel Bio-Sciences, Inc., a development stage company, produces, distributes, markets, and sells skin care products worldwide. The company primarily offers skin cream under the Rejuvel brand. It also intends to develop, build, and sell environmental management solutions that use electron particle accelerator technology for the treatment of drinking water, municipal and industrial wastewater, sludge, and produced water from oil and gas fracturing activities. The company was formerly known as Technology Applications International Corporation and changed its name to Rejuvel Bio-Sciences, Inc. in June 2015. Rejuvel Bio-Sciences, Inc. was founded in 2009 and is headquartered in Miami, Florida.
Receive News & Ratings for Solesence Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solesence and related companies with MarketBeat.com's FREE daily email newsletter.
